Safety of Breastfeeding During Favipiravir Therapy: A Case Study
Breastfeeding is not contraindicated in mothers undergoing favipiravir therapy and would be safer immediately before medication. Avoiding feeding at the peak time (1.3 hours after medication) minimizes infant exposure.
Authors
- Katsumi Mizuno (ORCID: https://orcid.org/0000-0002-6983-8851)
- Taro Kamiya
- Jumpei Saito (ORCID: https://orcid.org/0000-0003-4799-5562)
- Yuka Wada (ORCID: https://orcid.org/0000-0001-5277-9624)
- Yuka Maegawa
- Wakako Yamamoto
Institutions
- SHOWA Medical University (JP)
- National Center For Child Health and Development (JP)
- Mie Chuo Medical Center (JP)
Publication Details
- Journal
- Journal of Human Lactation
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1177/08903344241296034
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00